Neil Rimer
General Partner, Founder @ Index Ventures
Geneva, Switzerland
Neil Rimer is a Series B investor at Index Ventures in Geneva focused on Software and Financial Services. Neil Rimer is the General Partner and Founder of Index Ventures.
- Total investments:
- 90
- Last investment:
- Lead investor:
- 38%
Last updated:
For AI agents: llms.txt
Industries Neil Rimer invests in
Stages Neil Rimer invests in
Countries Neil Rimer invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Series A
- $3.3M–$19M
- Series B
- $6.7M–$66M
- Series C
- $12M–$86M
Investment Focus
Industry
- Software 12 (13%)
- Financial Services 6 (7%)
- SaaS 5 (6%)
- FinTech 5 (6%)
- Finance 5 (6%)
Stage
- Series B 23 (26%)
- Series A 21 (23%)
- Series C 10 (11%)
- Series D 9 (10%)
- Seed 7 (8%)
Country
- United States 14 (16%)
- United Kingdom 12 (13%)
- Germany 5 (6%)
- Norway 2 (2%)
- Spain 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Sequential Skin and Sequential Bio fall under the umbrella of Sequential: The Skin Microbiome Testing Co™Awarded the title "Most Significant" Testing Solution in the Industry - (Cosmetics & Toiletries, 2022), Sequential Bio is the skin microbiome company of the industry that specializes in microbiome testing and claimssubstantiation for brands formulating products for skin, scalp, vagina/vulva and oral care. Sequential offers a full end-to-end platform from study design, recruitment and testing, to analysis, and support on formulation development and certification. And it’s all done in vivo!Sequential Skin on the other hand is revolutionising skin health with the world's first consumer skin microbiome test. Formed of an award-winning team with a mission to empower individuals to make better-informed decisions about their skin health. (www.sequentialskin.com)Sequential is the product of the team's combined expertise in epigenetics, genetics, and microbiome research. Supported by Innovate UK, Enterprise SG, A*STAR, Genome Institute of Singapore, IndieBio New York, SOSV, Metaplanet, Scrum Ventures, CSB, and is a resident company of Johnson & Johnson Innovation – JLABS.Seen in Tatler, Cosmetic Designs, Tech Crunch, Genome Web, La Petite Journal, Global Wellness Summit, and Yahoo. | $3.5M / Seed / Mar 17, 2026 | ||
| Sofía is a health and technology company that offers health and medical insurance services. It provides a platform with health plans for major, minor and preventive medical expenses. Included in the plan are video consultations and one ambulance service per year. The company is offering a warm interaction as every touch point with the brand becomesa customized experience.Sofia was founded in 2018 and is based in Mexico. | $13.5M / Venture - Series Unknown / Dec 11, 2024 | ||
| Hoop helps make sure you don't miss a thing by automatically capturing your todos and action items from meetings and chat. | $5M / Seed / Jun 05, 2024 | ||
| Taxfix Group is Europe’s leading financial platform for digital tax filing, with over 6 million submitted tax returns in Europe. Taxfix’s mission is to fix finances for all, ensuring everyone can navigate their finances with confidence. The platform with its brands Taxfix, Steuerbot and TaxScouts offers a broad range of innovative tax filingsolutions tailored to diverse user needs and preferences: From the simple self-filing service app and browser solutions to the expert-service, a guided service where independent tax advisors handle the entire tax return process. | $220M / Series D / Apr 27, 2022 | ||
| Typeform is a no-code SaaS platform with thoughtfully-designed tools that help companies grow their business by engaging with their audience. Offering people-friendly forms, quizzes, surveys, and asynchronous video solutions, Typeform turns digital interactions into human connection. Launched in 2012, Typeform drives more than 500 million digitalinteractions per year and integrates with hundreds of other business-critical tools like HubSpot, Calendly, and Slack, to name a few. Typeform is headquartered in Barcelona, Spain with an office in San Francisco, California, and has a globally-distributed workforce of over 450 people. | $135M / Series C / Mar 10, 2022 | ||
| Maker is a wine marketplace featuring premium wines in innovative formats, so you can bring it and drink it anywhere. Maker Wine was founded in 2019 and is headquartered in Marin, California. | $2.3M / Seed / Nov 18, 2021 | ||
| Culture Amp was founded as a result of its members' first hand experiences with the challenge that fast growing organizations face when their core business expands faster than its people can adapt. With years of experience in enterprise organizations, CultureAmp's team has taken more than a walk in your shoes–they've been running inthem. They look to seize an opportunity for a new type of technology- technology that amplifies learning and drives culture, instead of hindering it. | $100M / Series F / Jul 29, 2021 | ||
| Built for collaboration and created with modern teams in mind, Pitch is changing how presentations are crafted and knowledge is shared. With a focus on real-time communication, smart workflows, and customizable templates, Pitch makes it easy for teams to work together to develop beautiful presentations. That’s why brands like Slack, Framer, andMetaLab love using Pitch. Founded by the team that created Wunderlist, Pitch has raised $50 million in funding since its founding in 2018. | $85M / Series B / May 20, 2021 | ||
| Nexthink is a global leader in digital experience management. The company's product allows enterprises to create highly productive digital workplaces for their employees by delivering optimal end-user experience. Through a unique combination of real-time analytics, automation and employee feedback across all endpoints, Nexthink helps ITteams meet the needs of the modern digital workplace. | $180.2M / Series D / Feb 08, 2021 | ||
| Sofía is a health and technology company that offers health and medical insurance services. It provides a platform with health plans for major, minor and preventive medical expenses. Included in the plan are video consultations and one ambulance service per year. The company is offering a warm interaction as every touch point with the brand becomesa customized experience.Sofia was founded in 2018 and is based in Mexico. | $19M / Series A / Nov 18, 2020 | ||
| See all 90 investments → | |||
Co-Investors
About Index Ventures
Index Ventures is a venture capital company that provides investment capital and strategic support to early-stage and growth-stage technology enterprises across sectors such as software, fintech, healthcare, and consumer services. It engages with entrepreneurial teams to assess business models, support scaling efforts, and provide guidance through successive development phases. The company’s services include sourcing investment opportunities, conducting due diligence, structuring financing deals, and offering ongoing advisory interactions with portfolio founders. Index Ventures also maintains a network of industry relationships and resources aimed at facilitating connections between founders, investors, and market opportunities. Its focus spans from initial seed rounds through later financing stages to help portfolio companies pursue expansion and market entry efforts.
Index Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Georgia Stevenson
Partner
|
|||
Gerald Rimer
Team Member
|
|||
Hannah Seal
Principal/Partner
|
|||
Jan Hammer
Investor & Partner
|
|||
Julia Andre
Principal/Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Neil Rimer invest in?
Neil Rimer invests primarily in Software, Financial Services and SaaS startups, most often at Series B and Series A stage. Most of the 90 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Neil Rimer's check size?
Neil Rimer typically joins rounds of $3.3M–$19M at Series A, $6.7M–$66M at Series B and $12M–$86M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Neil Rimer participates in.
How do I contact Neil Rimer?
Public channels for Neil Rimer include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Neil Rimer last invest?
The most recent investment recorded for Neil Rimer closed in Mar 2026. Shizune tracks 90 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
